Telomir Pharmaceuticals, Inc. jobs and careers

About Telomir Pharmaceuticals, Inc.

A novel treatment uniquely and selectively binds critical metals to interrupt enzyme function, returning cellular metals like Iron, copper, and zinc to homeostasis and turning off the underlying cause of cancer development and growth. By targeting specific classes of enzymes through its metal binding properties, Telomir 1 is believed to selectively affect the key processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.

Founded in 2022 by Chris Chapman.